Skip to content

Clinical trials

Lymphoma, Large-Cell, Anaplastic trials in Australia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lymphoma, Large-Cell, Anaplastic Country / region: Australia Clear all

10 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20032
20061
20132
20151
20201
20221
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed5
Recruiting2
Active, not recruiting1
No longer available1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Seagen Inc.2
Bristol-Myers Squibb1
Children's Oncology Group1
Corvus Pharmaceuticals, Inc.1
Hoffmann-La Roche1
NCIC Clinical Trials Group1
Novartis Pharmaceuticals1
Pfizer1
Turning Point Therapeutics, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lymphoma, Large-Cell, Anaplastic10
Lymphoma5
Lymphoma, Non-Hodgkin3
Burkitt Lymphoma2
Granuloma, Plasma Cell2
Hematologic Diseases2
Hodgkin Disease2
Immunoblastic Lymphadenopathy2
Lymphoma, Large B-Cell, Diffuse2
Lymphoma, T-Cell2

Trials

Showing 1 to 10 of 10. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.